Eli Lilly & Co. (LLY) Tops Q4 EPS by 34c, Revenue Beats, Offers Guidance

Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $2.49, $0.34 better than the analyst estimate of $2.15. Revenue for the quarter came in at $8 billion versus the consensus estimate of $6.74 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2022 EPS of $8.50-$8.65, versus the consensus of $7.54.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• John Wiley & Sons, Inc. (WLYB) Tops Q4 EPS by 12c; Offers Outlook
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group